B-Cell CLL/lymphoma 3 (BCL3) (Middle Region) Peptide
BCL3
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BCL3
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- PASTSQPDPS PDRSANTSPE SSSRLSSNGL LSASPSSSPS QSPPRDPPGF
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- BCL3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
- Synonymes
- BCL3 Peptide, AI528691 Peptide, Bcl-3 Peptide, BCL4 Peptide, D19S37 Peptide, B-cell CLL/lymphoma 3 Peptide, B cell leukemia/lymphoma 3 Peptide, BCL3 Peptide, Bcl3 Peptide
- Sujet
-
This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B.
Alias Symbols: BCL4, D19S37
Protein Size: 454 - ID gène
- 602
- NCBI Accession
- NM_005178, NP_005169
- UniProt
- P20749
-
Vous êtes ici:
